Research paves way for new forms of immunotherapy to treat people with Merkel cell cancer

FHS
July 1, 2024
1:41 pm

Scientists behind a new type of immunotherapy are demonstrating significant effects in laboratory experiments in cell samples from patients with the aggressive form of skin cancer, Merkel cell carcinoma.

Ohio State Wexner Medical Center wins $14 million award for aspirin dose study

A research team at The Ohio State University Wexner Medical Center and College of Medicine has been approved for a $14 million award from the

November 28, 2023

Novartis ends development of KRAS drug, citing ‘increasing options available’

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

May 31, 2024

Irish biotech collects $75M in Series B to start Phase 3 rare joint tumor trial

SynOx Therapeutics has completed a $75 million Series B raise to advance its monoclonal antibody drug through a registrational trial for a type of non-cancerous

April 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.